TickerFacts.

Lftd Partners Inc. (LIFD): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$552.9K
Year ended 2025-12-31
$529.1K
Trailing 12 months to 2026-06-30
+42.4%
3-year compound annual growth
+102.1%
5-year compound annual growth
2011-12-31: $45.0K2012-12-31: $34.8K2020-12-31: $16.4K2021-12-31: $90.1K2022-12-31: $191.5K2023-12-31: $425.6K2024-12-31: $520.6K2025-12-31: $552.9K$552.9K
2011-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$552.9K+6.2%2026-04-01, From 2025-01-01
2024-12-31$520.6K+22.3%2026-04-01, From 2024-01-01
2023-12-31$425.6K+122.2%2026-04-01, From 2023-01-01
2022-12-31$191.5K+112.5%2025-03-31, From 2022-01-01
2021-12-31$90.1K+450.2%2024-03-29, From 2021-01-01
2020-12-31$16.4Kn/a2023-03-21, From 2020-01-01
No annual figure between 2012-12-31 and 2020-12-31.
2012-12-31$34.8K-22.7%2013-04-01, From 2012-01-01
2011-12-31$45.0Kn/a2013-04-01, From 2011-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Lftd Partners Inc. (LIFD)2025-12-31$552.9K+6.2%
Sunshine Biopharma Inc. (SBFM)2025-12-31$332.1K+48.6%
BGM Group Ltd. (BGM)2025-09-30$1.46M+18.3%
Earth Science Tech, Inc. (ETST)2026-03-31$284.4K+427.1%
Bioharvest Sciences Inc. (BHST)2025-12-31$1.62M+29.8%
Biofrontera Inc. (BFRI)2025-12-31$138.0K-67.2%
Xilio Therapeutics, Inc. (XLO)2025-12-31$1.54M-6.3%
Foghorn Therapeutics Inc. (FHTX)2025-12-31$3.33M+6.8%
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$4.15M-15.4%

Compare LIFD, SBFM, BGM, ETST side by side · Screen every company in Pharmaceutical Preparations ↗